| abstract |
The problem of the present invention is that it has a non-nucleic acid structure and is based on excellent xanthine oxidase inhibitory action and uric acid level lowering action, such as hyperuricemia, gout, inflammatory bowel disease, diabetic nephropathy, diabetic retinopathy, etc. It is to provide a therapeutic or prophylactic agent. A novel triarylcarboxylic acid derivative characterized in that a heteroaryl group substituted with a carboxyl group and an aromatic ring group such as a phenyl group are substituted on the benzene ring at the para position, and further, the benzene ring has a cyano group Confirmed to have potent xanthine oxidase inhibitory action and uric acid level lowering action, and can be a therapeutic or preventive drug for good hyperuricemia, gout, inflammatory bowel disease, diabetic nephropathy, diabetic retinopathy, etc. As a result, the present invention was completed. |